Global Implantable Cardioverter Defibrillator Market by Type (Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D)), By Application (ASCs, Hospital, Clinic) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Implantable Cardioverter-Defibrillator Market size is expected to grow from $4,814.0 million in 2020 to $5,496.0 million by 2028 with a compound annual growth rate (CAGR) of 2.0% during the forecast period. The major factors driving this market are the increasing incidence of sudden cardiac death and heart failure due to the aging population along with advances in technology that allow for more accurate detection of irregular heart rhythm patterns which can lead to arrhythmias such as atrial fibrillation and ventricular tachycardia.
An Implantable Cardioverter-Defibrillator is also known as ICD or CRT-D is a medical device that's surgically implanted under the skin to treat life-threatening cardiac arrhythmias. The device monitors and treats abnormal heart rhythms by pacing (a series of low voltage electrical impulses), delivering high voltage shocks through electrodes on the leads, or both.
AICDs have been shown to reduce rates of death from sudden cardiac arrest in patients with certain types of ventricular tachycardia such as post-infarction cardiomyopathy and LQTS type II more than people without an AICD do.
On the basis of Types, the market is segmented into Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS):
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) is a device that delivers an electric shock to the heart in order to prevent sudden cardiac death. Patients with S-ICD have their own primary care physician who will determine when and if they need shocks, as well as how many are needed for each episode of tachycardia or ventricular fibrillation.
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs):
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) can be defined as an implantable device that is surgically implanted under the skin, usually in a major vein near the heart. They are used to treat and prevent sudden cardiac arrest (SCA) by defibrillating or pacing when necessary. The T-ICDs have a lead wire with electrodes at its end which is inserted through an opening in the groin into one of four chambers of the heart.
Cardiac Resynchronization Therapy Defibrillator (CRT-D):
The CRT-D is a device that synchronizes the heart's electrical impulses to help prevent sudden cardiac arrest and rhythm disturbance. The device can also reduce symptoms of congestive heart failure, including shortness of breath or ankle swelling.
On the basis of Application, the market is segmented into Hospitals and Clinics. An Implantable Cardioverter-Defibrillator can be used in hospitals as a device that is implanted inside the chest to monitor and correct an arrhythmia. It monitors heart rhythms, knows when to deliver pulses of electric energy to restore normal rhythm or a shock if necessary. The battery has typically lasted years without needing replacement and it allows for patients who are otherwise at risk from sudden death due to abnormal heartbeat rhythms (i.e., ventricular tachycardia) because medications have not been working well enough.
On the basis of Region, the market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. The North American market for implantable cardioverter defibrillators (ICDs) is projected to grow at a faster pace. The key factors that are driving this growth are the increasing number of cardiac events, increasing prevalence of cardiovascular diseases, and improved reimbursement scenario in developed economies such as Canada and Mexico.
The European market is projected to grow significantly. This growth can be attributed to the rapidly aging population who are susceptible to heart disease or frequent arrhythmias which will require long-term therapy through implanted devices.
The Asia Pacific is also expected to register robust growth due mainly to rising in living standards leading people towards high-risk lifestyle changes like eating habits, tobacco use, or sedentary lifestyle which are the major driving factors for chronic diseases such as cardiac problems.
MENA region has been witnessing a surge in demand from key countries namely Saudi Arabia, Egypt, and Israel among others due to favorable policy initiatives along with increasing awareness on benefits these devices provide leading them to become the preferred treatment option available for patients suffering from cardiovascular conditions.
Latin America too will account for significant gains during the forecast period owing mainly to a due increase in the prevalence of chronic diseases like hypertension and diabetes.
Up Market Research published a new report titled “Implantable Cardioverter Defibrillator Market research report which is segmented by Types (Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D)), By Applications (ASCs, Hospital, Clinic), By Players/Companies ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), Abbott, Koninklijke Philips N.V. (Netherlands), Medtronic Plc, PHILIPS HEALTHCARE, Sorin Group, Nihon Kohden Corporation”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Implantable Cardioverter Defibrillator Market Research Report |
| By Type | Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D) |
| By Application | ASCs, Hospital, Clinic |
| By Companies | ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), Abbott, Koninklijke Philips N.V. (Netherlands), Medtronic Plc, PHILIPS HEALTHCARE, Sorin Group, Nihon Kohden Corporation |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 235 |
| Number of Tables & Figures | 165 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Implantable Cardioverter Defibrillator Market Report Segments:
The market is segmented by Type Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D) and By Application ASCs, Hospital, Clinic.
Some of the companies that are profiled in this report are:
- ZOLL Medical Corporation (US)
- Boston Scientific Corporation (US)
- BIOTRONIK SE & Co. KG (Germany)
- Medtronic PLC (Ireland)
- Abbott
- Koninklijke Philips N.V. (Netherlands)
- Medtronic Plc
- PHILIPS HEALTHCARE
- Sorin Group
- Nihon Kohden Corporation
Implantable Cardioverter Defibrillator Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Implantable Cardioverter Defibrillator Market
Overview of the regional outlook of the Implantable Cardioverter Defibrillator Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Implantable Cardioverter Defibrillator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Implantable Cardioverter Defibrillator Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
2. Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
7. By Application:1. ASCs
2. Hospital
3. Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Cardioverter Defibrillator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Implantable Cardioverter Defibrillator Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Cardioverter Defibrillator Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Cardioverter Defibrillator Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Cardioverter Defibrillator Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Cardioverter Defibrillator Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Cardioverter Defibrillator Market Size & Forecast, 2018-2028
4.5.1 Implantable Cardioverter Defibrillator Market Size and Y-o-Y Growth
4.5.2 Implantable Cardioverter Defibrillator Market Absolute $ Opportunity
Chapter 5 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Implantable Cardioverter Defibrillator Market Size Forecast by Type
5.2.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.2.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
5.2.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Implantable Cardioverter Defibrillator Market Size Forecast by Applications
6.2.1 ASCs
6.2.2 Hospital
6.2.3 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Cardioverter Defibrillator Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Implantable Cardioverter Defibrillator Analysis and Forecast
9.1 Introduction
9.2 North America Implantable Cardioverter Defibrillator Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Implantable Cardioverter Defibrillator Market Size Forecast by Type
9.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
9.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
9.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Implantable Cardioverter Defibrillator Market Size Forecast by Applications
9.10.1 ASCs
9.10.2 Hospital
9.10.3 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Implantable Cardioverter Defibrillator Analysis and Forecast
10.1 Introduction
10.2 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Type
10.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
10.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
10.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Applications
10.10.1 ASCs
10.10.2 Hospital
10.10.3 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Implantable Cardioverter Defibrillator Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Type
11.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
11.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
11.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Applications
11.10.1 ASCs
11.10.2 Hospital
11.10.3 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Implantable Cardioverter Defibrillator Analysis and Forecast
12.1 Introduction
12.2 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Type
12.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
12.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
12.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Applications
12.10.1 ASCs
12.10.2 Hospital
12.10.3 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Type
13.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
13.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
13.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Applications
13.10.1 ASCs
13.10.2 Hospital
13.10.3 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Cardioverter Defibrillator Market: Competitive Dashboard
14.2 Global Implantable Cardioverter Defibrillator Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ZOLL Medical Corporation (US)
14.3.2 Boston Scientific Corporation (US)
14.3.3 BIOTRONIK SE & Co. KG (Germany)
14.3.4 Medtronic PLC (Ireland)
14.3.5 Abbott
14.3.6 Koninklijke Philips N.V. (Netherlands)
14.3.7 Medtronic Plc
14.3.8 PHILIPS HEALTHCARE
14.3.9 Sorin Group
14.3.10 Nihon Kohden Corporation
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Cardioverter Defibrillator Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Cardioverter Defibrillator Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Cardioverter Defibrillator Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Cardioverter Defibrillator Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Cardioverter Defibrillator Market Size & Forecast, 2018-2028
4.5.1 Implantable Cardioverter Defibrillator Market Size and Y-o-Y Growth
4.5.2 Implantable Cardioverter Defibrillator Market Absolute $ Opportunity
Chapter 5 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Implantable Cardioverter Defibrillator Market Size Forecast by Type
5.2.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.2.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
5.2.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Implantable Cardioverter Defibrillator Market Size Forecast by Applications
6.2.1 ASCs
6.2.2 Hospital
6.2.3 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Cardioverter Defibrillator Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Cardioverter Defibrillator Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Implantable Cardioverter Defibrillator Analysis and Forecast
9.1 Introduction
9.2 North America Implantable Cardioverter Defibrillator Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Implantable Cardioverter Defibrillator Market Size Forecast by Type
9.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
9.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
9.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Implantable Cardioverter Defibrillator Market Size Forecast by Applications
9.10.1 ASCs
9.10.2 Hospital
9.10.3 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Implantable Cardioverter Defibrillator Analysis and Forecast
10.1 Introduction
10.2 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Type
10.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
10.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
10.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Implantable Cardioverter Defibrillator Market Size Forecast by Applications
10.10.1 ASCs
10.10.2 Hospital
10.10.3 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Implantable Cardioverter Defibrillator Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Type
11.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
11.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
11.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Implantable Cardioverter Defibrillator Market Size Forecast by Applications
11.10.1 ASCs
11.10.2 Hospital
11.10.3 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Implantable Cardioverter Defibrillator Analysis and Forecast
12.1 Introduction
12.2 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Type
12.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
12.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
12.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Implantable Cardioverter Defibrillator Market Size Forecast by Applications
12.10.1 ASCs
12.10.2 Hospital
12.10.3 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Type
13.6.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
13.6.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
13.6.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Implantable Cardioverter Defibrillator Market Size Forecast by Applications
13.10.1 ASCs
13.10.2 Hospital
13.10.3 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Cardioverter Defibrillator Market: Competitive Dashboard
14.2 Global Implantable Cardioverter Defibrillator Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ZOLL Medical Corporation (US)
14.3.2 Boston Scientific Corporation (US)
14.3.3 BIOTRONIK SE & Co. KG (Germany)
14.3.4 Medtronic PLC (Ireland)
14.3.5 Abbott
14.3.6 Koninklijke Philips N.V. (Netherlands)
14.3.7 Medtronic Plc
14.3.8 PHILIPS HEALTHCARE
14.3.9 Sorin Group
14.3.10 Nihon Kohden Corporation
Segments Covered in the Report
The global Implantable Cardioverter Defibrillator market has been segmented based on
By Types
The global Implantable Cardioverter Defibrillator market has been segmented based on
By Types
- Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
- Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
- Cardiac Resynchronization Therapy Defibrillator (CRT-D)
- ASCs
- Hospital
- Clinic
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- ZOLL Medical Corporation (US)
- Boston Scientific Corporation (US)
- BIOTRONIK SE & Co. KG (Germany)
- Medtronic PLC (Ireland)
- Abbott
- Koninklijke Philips N.V. (Netherlands)
- Medtronic Plc
- PHILIPS HEALTHCARE
- Sorin Group
- Nihon Kohden Corporation
Our Clients
Related Reports
Some other reports from this category!
